:,

Larissa Anastacio da Costa Carvalho1,2, Isabella Harumi Yonehara Noma2, Adriana Hiromi Uehara2

  • 1Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL 33612, USA.

概括

黑色素瘤亚种群表现出影响BRAF抑制剂耐药性的独特特征. 降低色素和抗氧化防御,如PRDX1,与耐药克隆的治疗耐药性有关.